Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Miller

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|October 2, 2002
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppressionAndrew N Phillips, Schlomo Staszewski, Fiona Lampe, et al.
Journal of Virus Eradication|March 10, 2017
Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultationJonathan Liu, Pedro Goicochea, Timothy Block, et al.
AIDS (London, England)|September 2, 2025
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention researchRobin Schaefer, Breanne Lievense, Suzanne Day, et al.
Gastroenterology|May 1, 2020
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver ForumMazen Noureddin, Jean L Chan, Katherine Barradas, et al.
Nature Reviews. Gastroenterology & Hepatology|June 10, 2020
NAFLD - sounding the alarm on a silent epidemicJeffrey V Lazarus, Massimo Colombo, Helena Cortez-Pinto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2020
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysisRyan T Anderson, Hannah S J Choi, Oliver Lenz, et al.
Hepatology (Baltimore, Md.)|April 30, 2019
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver ForumAmanda Cheung, Brent A Neuschwander-Tetri, David E Kleiner, et al.
Plos Medicine|July 14, 2011
Global pharmacovigilance for antiretroviral drugs: overcoming contrasting prioritiesNyasha Bakare, Ivor Ralph Edwards, Andy Stergachis, et al.
Clinical Pharmacology and Therapeutics|December 23, 2022
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design ProjectNeil Parkin, Fei Gao, Eduard Grebe, et al.
Journal of Viral Hepatitis|December 13, 2019
Liver safety assessment in clinical trials of new agents for chronic hepatitis BRobert J Fontana, Mark I Avigan, Harry L A Janssen, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|October 2, 2002
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppressionAndrew N Phillips, Schlomo Staszewski, Fiona Lampe, et al.
Journal of Virus Eradication|March 10, 2017
Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultationJonathan Liu, Pedro Goicochea, Timothy Block, et al.
AIDS (London, England)|September 2, 2025
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention researchRobin Schaefer, Breanne Lievense, Suzanne Day, et al.
Gastroenterology|May 1, 2020
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver ForumMazen Noureddin, Jean L Chan, Katherine Barradas, et al.
Nature Reviews. Gastroenterology & Hepatology|June 10, 2020
NAFLD - sounding the alarm on a silent epidemicJeffrey V Lazarus, Massimo Colombo, Helena Cortez-Pinto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2020
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysisRyan T Anderson, Hannah S J Choi, Oliver Lenz, et al.
Hepatology (Baltimore, Md.)|April 30, 2019
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver ForumAmanda Cheung, Brent A Neuschwander-Tetri, David E Kleiner, et al.
Plos Medicine|July 14, 2011
Global pharmacovigilance for antiretroviral drugs: overcoming contrasting prioritiesNyasha Bakare, Ivor Ralph Edwards, Andy Stergachis, et al.
Clinical Pharmacology and Therapeutics|December 23, 2022
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design ProjectNeil Parkin, Fei Gao, Eduard Grebe, et al.
Journal of Viral Hepatitis|December 13, 2019
Liver safety assessment in clinical trials of new agents for chronic hepatitis BRobert J Fontana, Mark I Avigan, Harry L A Janssen, et al.
Pageof 11